Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-interventional, Long-term Follow-up of Subjects Who Completed ApoGraft-01 Study

NCT03260101 is registered in ClinicalTrials.gov with Cellect Biotechnology as lead sponsor.

NCT NCT03260101
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03260101 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-interventional, Long-term Follow-up of Subjects Who Completed ApoGraft-01 Study
Lead sponsor
Cellect Biotechnology
Phase
Observational
Overall status
Unknown status
Start date
June 10, 2018
Completion date
December 31, 2021
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia (all), acute myelogenous leukemia (aml), hodgkin lymphoma, adult, non hodgkin lymphoma (nhl)